| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892
The MAGE-1 gene codes for a tumor-specific antigen, MZ2-E, that elicited a cytotoxic T-lymphocyte response in the melanoma patient from whom it was derived. We have developed a simplified method, using polymerase chain reaction amplification of exon 3 followed by restriction enzyme pattern analysis, to distinguish expression of the MAGE-1 gene from MAGE-2 and MAGE-3, other members of this gene family. MAGE-1 mRNA was expressed in 53% of 17 melanoma lines, two of seven Epstein-Barr virus-transformed B-cell lines, and 2 of 5 breast cell lines including a line established from normal breast epithelium. MAGE-1 is not likely to be the common melanoma antigen recognized by the other HLA-A1- or HLA-A2-restricted cytotoxic T-lymphocytes examined in this study, but the fact that it is expressed in about 50% of melanoma cell lines makes it a reasonable target for the immunotherapy of patients bearing HLA-A1.
1 To whom requests for reprints should be addressed, at National Cancer Institute, NIH, 9000 Rockville Pike, Building 10, Room 2B47, Bethesda, MD 20892.
Received 9/ 8/92. Accepted 11/11/92.
This article has been cited by other articles:
|
|
 |
|
  S. Vatolin, Z. Abdullaev, S. D. Pack, P. T. Flanagan, M. Custer, D. I. Loukinov, E. Pugacheva, J. A. Hong, H. Morse III, D. S. Schrump, et al. Conditional Expression of the CTCF-Paralogous Transcriptional Factor BORIS in Normal Cells Results in Demethylation and Derepression of MAGE-A1 and Reactivation of Other Cancer-Testis Genes Cancer Res., September 1, 2005; 65(17): 7751 - 7762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Lake, M. L. Salgaller, P. van der Bruggen, R. M. Bernstein, and J. J. Marchalonis Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1 Int. Immunol., May 1, 1999; 11(5): 745 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Chen, S.-H. Lin, L. W. K. Chung, and R. A. Sikes Isolation and Characterization of PAGE-1 and GAGE-7. NEW GENES EXPRESSED IN THE LNCaP PROSTATE CANCER PROGRESSION MODEL THAT SHARE HOMOLOGY WITH MELANOMA-ASSOCIATED ANTIGENS J. Biol. Chem., July 10, 1998; 273(28): 17618 - 17625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tuting, C. C. Wilson, D. M. Martin, Y. L. Kasamon, J. Rowles, D. I. Ma, C. L. Slingluff Jr., S. N. Wagner, P. van der Bruggen, J. Baar, et al. Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-{alpha} J. Immunol., February 1, 1998; 160(3): 1139 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Freilich, C. Balmaceda, A. D. Seidman, M. Rubin, and L. M. DeAngelis Motor neuropathy due to docetaxel and paclitaxel Neurology, July 1, 1996; 47(1): 115 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.H.E. Hilkens, J. Verweij, G. Stoter, Ch.J. Vecht, W. L.J. van Putten, and M. J. van den Bent Peripheral neurotoxicity induced by docetaxel Neurology, January 1, 1996; 46(1): 104 - 108. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
